SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001689813-21-000057
Filing Date
2021-03-17
Accepted
2021-03-17 16:44:42
Documents
17
Period of Report
2021-03-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20210317.htm   iXBRL 8-K 33898
2 EX-1.1 a2021marchbhvnunderwrittena.htm EX-1.1 243814
3 EX-5.1 a2021marchbhvnunderwritten.htm EX-5.1 25209
9 GRAPHIC image_01.jpg GRAPHIC 11456
  Complete submission text file 0001689813-21-000057.txt   511933

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20210317.xsd EX-101.SCH 2441
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20210317_cal.xml EX-101.CAL 722
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20210317_def.xml EX-101.DEF 1655
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20210317_lab.xml EX-101.LAB 23938
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20210317_pre.xml EX-101.PRE 12646
10 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20210317_htm.xml XML 10496
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 21751111
SIC: 2834 Pharmaceutical Preparations